Neuroone Med Technologies Co.
13F holders, Q2 2026 (June 30)2holders −29
0new positions
12sold out
$3.04avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Neuroone Med Technologies Co. in their 13F filings, down 29 from Q1 2026. 0 opened new positions and 12 sold out. The largest holders were Princeton Global Asset Management LLC ($9K) and Quent Capital, LLC ($18).
- Company
- Neuroone Med Technologies Co.
- CUSIP
- 64130M209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 12 | $227K |
All 13F filers, Q1 2026 → Q2 2026: 306,193 shares sold, net −306,193 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Princeton Global Asset Management LLC | 0.00% | Reduce -83.3% | 2,805 | $9K |
| Quent Capital, LLC | 0.00% | Reduce -85.0% | 6 | $18 |
"% of holder's portfolio" is NEUROONE MED TECHNOLOGIES CO's weight in each manager's 13F, not the share of Neuroone Med Technologies Co. the manager owns.